Guardant Health grows with Shield blood CRC screening, Quest deal, 50M reach, 335% surge, and FY25 revenue $981M up 33%. Read ...
Stool DNA testing climbed sharply after the pandemic began while colonoscopy and fecal immunochemical test use fell, a study of nearly 25 million privately insured Blue Cross Blue Shield beneficiaries ...
New American Cancer Society research reveals colorectal cancer deaths rising among younger adults, while other cancer ...
The funding will be used to lead a five-year statewide effort known as Promoting Resource and Outreach to Enhance Colorectal ...